BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29145565)

  • 1. Outcome prediction in patients with localized soft tissue sarcoma: which tool is the best?
    Kasper B; Wardelmann E
    Ann Oncol; 2018 Feb; 29(2):297-298. PubMed ID: 29145565
    [No Abstract]   [Full Text] [Related]  

  • 2. The Genomic Grade Index predicts postoperative clinical outcome in patients with soft-tissue sarcoma.
    Bertucci F; De Nonneville A; Finetti P; Perrot D; Nilbert M; Italiano A; Le Cesne A; Skubitz KM; Blay JY; Birnbaum D
    Ann Oncol; 2018 Feb; 29(2):459-465. PubMed ID: 29069276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-expression profiling to classify soft-tissue sarcomas.
    Dirix LY; van Oosterom AT
    Lancet; 2002 Apr; 359(9314):1263-4. PubMed ID: 11965266
    [No Abstract]   [Full Text] [Related]  

  • 4. DNA methylation patterns-based subtype distinction and identification of soft tissue sarcoma prognosis.
    Li K; Wu Z; Yao J; Fan J; Wei Q
    Medicine (Baltimore); 2021 Feb; 100(5):e23787. PubMed ID: 33592836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A current perspective on the role for molecular studies in soft tissue tumor pathology.
    Dei Tos AP
    Semin Diagn Pathol; 2013 Nov; 30(4):375-81. PubMed ID: 24342291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The pathology of soft tissue sarcomas].
    Schmidt D
    Radiologe; 1992 Dec; 32(12):579-83. PubMed ID: 1492148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refinements in Sarcoma Classification in the Current 2013 World Health Organization Classification of Tumours of Soft Tissue and Bone.
    Jo VY; Doyle LA
    Surg Oncol Clin N Am; 2016 Oct; 25(4):621-43. PubMed ID: 27591490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soft tissue sarcomas: are all soft tissue sarcomas treated with the same drugs?
    Blay JY; Cassier PA; Ray-Coquard I
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S385-8. PubMed ID: 21944026
    [No Abstract]   [Full Text] [Related]  

  • 9. Prediction of survival in patients with high-grade soft tissue sarcoma.
    Rööser B; Berg NO; Ranstam J; Rydholm A; Willén H
    Int Orthop; 1990; 14(2):199-204. PubMed ID: 2373569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in soft tissue sarcoma. A review and the Scandinavian Sarcoma Group experience.
    Rydholm A; Gustafson P; Alvegård TA; Saeter G; Blomqvist C
    Acta Orthop Scand Suppl; 1999 Jun; 285():50-7. PubMed ID: 10429623
    [No Abstract]   [Full Text] [Related]  

  • 11. CHIPing soft tissue tumors: will the paradigms be changed?
    Oliveira AM; Fletcher JA
    Adv Anat Pathol; 2003 Jan; 10(1):1-7. PubMed ID: 12502964
    [No Abstract]   [Full Text] [Related]  

  • 12. Coexpression of survivin and TERT in soft-tissue sarcoma.
    Daidone MG; Porta CD; Pilotti S; Zaffaroni N
    Lancet; 2002 Sep; 360(9336):877. PubMed ID: 12243951
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk assignment in pediatric soft-tissue sarcomas: an evolving molecular classification.
    Qualman SJ; Morotti RA
    Curr Oncol Rep; 2002 Mar; 4(2):123-30. PubMed ID: 11822984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The surgeon as a leader in cancer care: lessons learned from the study of soft tissue sarcoma.
    Brennan MF
    J Am Coll Surg; 1996 Jun; 182(6):520-9. PubMed ID: 8646353
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pathological evaluation of soft tissue sarcoma for diagnosis, prognosis and treatment].
    Yamaguchi U; Hasegawa T
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1340-5. PubMed ID: 15446553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current aspects of the pathology of soft tissue sarcomas.
    Fisher C
    Semin Radiat Oncol; 1999 Oct; 9(4):315-27. PubMed ID: 10516379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soft tissue sarcomas and p53 mutations.
    Taubert H; Meye A; Würl P
    Mol Med; 1998 Jun; 4(6):365-72. PubMed ID: 10780879
    [No Abstract]   [Full Text] [Related]  

  • 18. Staging and prognostic factors in soft tissue sarcoma.
    Pisters PW; Pollock RE
    Semin Radiat Oncol; 1999 Oct; 9(4):307-14. PubMed ID: 10516378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone and soft tissue sarcomas: summary of the Third United States/Japan Clinical Trials Summit (Seattle, Washington).
    Uchida A; Fukushima M; Rothenberg ML; Coltman CA
    J Cancer Res Clin Oncol; 1997; 123(11-12):674-7. PubMed ID: 9620228
    [No Abstract]   [Full Text] [Related]  

  • 20. Systemic adjuvant chemotherapy for soft tissue sarcomas.
    Zalupski MM; Baker LH
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):787-800. PubMed ID: 7490241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.